Persistent inflammation and immune activation contribute to cholestasis in patients receiving home parenteral nutrition

References 

1. Broviac JW, Scribner CH. The artificial gut (two years experience with total parenteral nutrition in the home). Gastroenterology. 1972;67:727
2. Sheldon GF, Peterson SR, Sanders R. Hepatic dysfunction during hyperalimentation. Arch Surg. 1978;113:504
   • MEDLINE
3. Whitington PF. Cholestasis associated with total parenteral nutrition in infants. Hepatology. 1985;5:693
   • MEDLINE
   • CrossRef
4. Baker AL, Rosenberg IH. Hepatic complications of total parenteral nutrition. Am J Med. 1987;82:489
   • Abstract
   • Full-Text PDF (4489 KB)
   • CrossRef
5. Sax HC, Bower RH. Hepatic complications of total parenteral nutrition. JPEN. 1988;12:615
6. Clarke PJ, Ball MJ, Kettlewell MGW. Liver function tests in patients receiving parenteral nutrition. JPEN. 1991;15:54
7. Bowyer B, Fleming C, Ludwig J, et al.  Does long term home parenteral nutrition in adult patients cause chronic liver disease?. JPEN. 1985;9:11
8. Quigley EMM, Marsh MN, Shaffer JL, et al.  Hepatobiliary complications of total parenteral nutrition. Gastroenterology. 1993;104:286
   • Abstract
9. Matsui J, Cameron RG, Kurian R, Kuo GC, Jeejeebhoy KN. Nutritional, hepatic, and metabolic effects of cachectin/tumor necrosis factor in rats receiving total parenteral nutrition. Gastroenterology. 1993;104:235
   • Abstract
10. Moseley RH, Wang W, Takeda H, et al.  Effect of endotoxin on bile acid transport in rat liver (a potential model for sepsis-associated cholestasis). Am J Physiol. 1996;271:G137
    • MEDLINE
11. Nanji AA, Anderson FH. Sensitivity and specificity of liver function tests in the detection of parenteral nutrition-associated cholestasis. JPEN. 1985;9:307
12. Campos AC, Oler A, Meguid MM, Chen T-Y. Liver biochemical and histological changes with graded amounts of total parenteral nutrition. Arch Surg. 1990;125:447
    • MEDLINE
13. Meguid MM, Chen T-Y, Yang Z-J, et al.  Effects of continuous graded total parenteral nutrition on feeding indexes and metabolic concomitants in rats. Am J Physiol. 1991;260:E126
    • MEDLINE
14. Fromenty B, Pessayre D. Inhibition of mitochondrial beta-oxidation as a mechanism of hepatotoxicity. Pharmacol Ther. 1995;67:101
    • MEDLINE
    • CrossRef
15. Rashid A, Koteish AK, Cortez-Pinto H, et al.  Subcellular localization of uncoupling receptor (UCP)2 and evidence for increased UCP2 expression in nonalcoholic steatohepatitis (abstract). Hepatology. 1999;30:980
16. Leclercq IA, Field J, Bell DR, Farrell GC, Robertson GR. Involvment of CYP2E1 and CYP4A in the pathogenesis of experimental nonalcoholic steatohepatitis (insights from studies in CYP2E1 knockout mice (abstract)). Hepatology. 1999;30:1055
17. Messing B, Colombel JF, Heresbach D, Chazouillères O, Galian A. Chronic cholestasis and macronutrient excess in patients treated with prolonged parenteral nutrition. Nutrition. 1992;8:30
    • MEDLINE
18. Cavicchi M, Beau P, Crenn P, Degott C, Messing B. Prevalence of liver disease in patients receiving home parenteral nutrition for permanent intestinal failure. Ann Intern Med. 2000;132:525
    • MEDLINE
19. Raina N, Cameron RG, Jeejeebhoy KN. Gastrointestinal, hepatic, and metabolic effects of enteral and parenteral nutrition in rats infused with tumor necrosis factor. JPEN. 1997;21:7
20. Heyman M, Darmon N, Dupont C, et al.  Mononuclear cells from infants allergic to cow’s milk secrete tumor necrosis factor α, altering intestinal function. Gastroenterology. 1994;106:1514
    • Abstract
    • Full-Text PDF (1058 KB)
21. Keith ME, Norwich KH, Jeejeebhoy KN. Nutritional support affects the distribution and organ uptake of cachectin/tumor necrosis factor in rats. JPEN. 1995;19:341